AXID Drug Patent Profile
✉ Email this page to a colleague
When do Axid patents expire, and what generic alternatives are available?
Axid is a drug marketed by Smithkline Beecham, Braintree, and Haleon Us Holdings. and is included in three NDAs.
The generic ingredient in AXID is nizatidine. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the nizatidine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Axid
A generic version of AXID was approved as nizatidine by EPIC PHARMA LLC on July 5th, 2002.
Summary for AXID
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 82 |
Patent Applications: | 4,035 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AXID at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AXID
Paragraph IV (Patent) Challenges for AXID
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
AXID | Oral Solution | nizatidine | 15 mg/mL | 021494 | 1 | 2008-05-14 |
US Patents and Regulatory Information for AXID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-001 | Apr 12, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Haleon Us Holdings | AXID AR | nizatidine | TABLET;ORAL | 020555-001 | May 9, 1996 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-002 | Apr 12, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Braintree | AXID | nizatidine | SOLUTION;ORAL | 021494-001 | May 25, 2004 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AXID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-002 | Apr 12, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-001 | Apr 12, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-001 | Apr 12, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-002 | Apr 12, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-002 | Apr 12, 1988 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AXID
See the table below for patents covering AXID around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Ireland | 812285 | ⤷ Try a Trial | |
German Democratic Republic | 200371 | VERFAHREN ZUR HERSTELLUNG VON 2,4-DISUBSTITUIERTEN THIAZOLEN | ⤷ Try a Trial |
Australia | 542553 | ⤷ Try a Trial | |
Finland | 76570 | ⤷ Try a Trial | |
Kenya | 3680 | IMPROVEMENTS IN OR RELATING TO 2,4-DISUBSTITUTED THIAZOLE DERIVATIVES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |